Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Paul Morgan

Showing results (51-60 of 249) with videos related to

Pageof 25
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2014
Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in miceKees Fluiter, Anne Loes Opperhuizen, B Paul Morgan, et al.
Molecular Immunology|December 5, 2009
The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout miceRuth D Lewis, Christopher L Jackson, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
Retraction. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, B Paul Morgan, Marieta M Ruseva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decayClaire L Harris, David M Pettigrew, Susan M Lea, et al.
Immunology and Cell Biology|July 11, 2012
Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapiesEmma Kempshall, Simon Thebault, B Paul Morgan, et al.
Biology of Reproduction|December 17, 2004
Expression of CD46 in developing rat spermatozoa: ultrastructural localization and utility as a marker of the various stages of the seminiferous tubuliMasashi Mizuno, Claire L Harris, Norihiko Suzuki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1qEamon P McGreal, Nobunao Ikewaki, Hiroyasu Akatsu, et al.
European Journal of Immunology|April 13, 2007
CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanismsM Paula Longhi, Anwen Williams, Matthew Wise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 28, 2010
Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, Marieta M Ruseva, B Paul Morgan, et al.
European Journal of Immunology|March 21, 2003
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59Aled Clayton, Claire L Harris, Jacquelyn Court, et al.
Pageof 25

Showing results (51-60 of 249) with videos related to

Sort By:
Pageof 25
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2014
Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in miceKees Fluiter, Anne Loes Opperhuizen, B Paul Morgan, et al.
Molecular Immunology|December 5, 2009
The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout miceRuth D Lewis, Christopher L Jackson, B Paul Morgan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 14, 2011
Retraction. Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, B Paul Morgan, Marieta M Ruseva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decayClaire L Harris, David M Pettigrew, Susan M Lea, et al.
Immunology and Cell Biology|July 11, 2012
Complement-induced protection: an explanation for the limitations of cell-based tumour immunotherapiesEmma Kempshall, Simon Thebault, B Paul Morgan, et al.
Biology of Reproduction|December 17, 2004
Expression of CD46 in developing rat spermatozoa: ultrastructural localization and utility as a marker of the various stages of the seminiferous tubuliMasashi Mizuno, Claire L Harris, Norihiko Suzuki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1qEamon P McGreal, Nobunao Ikewaki, Hiroyasu Akatsu, et al.
European Journal of Immunology|April 13, 2007
CD59a deficiency exacerbates influenza-induced lung inflammation through complement-dependent and -independent mechanismsM Paula Longhi, Anwen Williams, Matthew Wise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 28, 2010
Targeting neural-restrictive silencer factor sensitizes tumor cells to antibody-based cancer immunotherapy in vitro via multiple mechanismsMartin V Kolev, Marieta M Ruseva, B Paul Morgan, et al.
European Journal of Immunology|March 21, 2003
Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59Aled Clayton, Claire L Harris, Jacquelyn Court, et al.
Pageof 25